We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biofrontera Inc | NASDAQ:BFRI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 2.80% | 1.10 | 1.06 | 1.20 | 1.1747 | 1.04 | 1.10 | 95,455 | 23:00:01 |
Biofrontera Inc. · 120 Presidential Way, Suite 330 · Woburn, MA 01801 · USA
VIA EDGAR
February 20, 2024
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re: | Biofrontera Inc. Request for Withdrawal of Registration Statement on Form S-1 File No. 333-276535 |
Dear Mr. Edwards:
Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), Biofrontera Inc. (the “Company”) hereby respectfully requests that the Company’s Registration Statement on Form S-1 (File No. 333-276535), together with all exhibits thereto, and as subsequently amended from time to time (the “Registration Statement”), initially filed with the Securities and Exchange Commission (the “Commission”) on January 17, 2024, be withdrawn, effective as of the date hereof.
The Company is withdrawing the Registration Statement because it no longer plans to consummate the offering described in the Registration Statement, and hereby confirms that no securities registered under the Registration Statement have been sold. The Registration Statement has not been declared effective. Based on the foregoing, the Company submits that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a).
The Company requests that, in accordance with Rule 457(p) of the Securities Act and subject to compliance with the requirements thereof, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for potential future use.
Please contact Stephen Older at McGuireWoods LLP, at (212) 548-2122, or in his absence Andrew Terjesen at (704) 343-2024, if you have any other questions or concerns regarding this matter.
Very truly yours, | ||
Biofrontera Inc. | ||
/s/ E. Fred Leffler, III | ||
Name: | E. Fred Leffler, III | |
Title: | Chief Financial Officer |
cc: | Hermann Luebbert |
Biofrontera Inc. | |
Stephen Older | |
McGuireWoods LLP |
Biofrontera Inc. . 120 Presidential Way, Suite 330 . Woburn, MA 01801 . USA
Contact Phone +1 781 245 1325 . E-Mail info-us@biofrontera.com . www.biofrontera-us.com
1 Year Biofrontera Chart |
1 Month Biofrontera Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions